Educational Activities Archives

A patient with opioid use disorder weighs the options for medication assisted treatment and chooses naltrexone. Dr. John Mariani, a Providers Clinical Support System Clinical expert, explains what she can expect before the actual shot.

Dr. John Mariani, a Providers Clinical Support System Clinical expert, explains what a patient can expect when she begins taking naltrexone for the treatment of opioid use disorder.

Dr. Sanchit Maruti, a Providers Clinical Support System Clinical expert, gives a quick primer on the medications used to treat opioid use disorder.

Dr. Hillary Kunins, a Providers Clinical Support System Clinical expert, discusses the importance of treating opioid use disorder using medications.

Pediatrician Timothy Brennan, a Providers Clinical Support System Clinical expert, explains the different options available to a teenager who wants to use medication assisted treatment to stop using heroin.

Today we will be talking about the use of naltrexone for the treatment of opioid use disorder therapy. Naltrexone is an opioid blocker, or antagonist, that has limited prevalence of use compared with buprenorphine, a partial agonist, and methadone, a long-acting agonist. Joining us for this conversation is Dr. Adam Bisaga, an academic psychiatrist, educator and clinician. He is a Professor of Psychiatry at the Columbia University Medical Center, and a Research Scientist at the New York State Psychiatric Institute. He was a recipient of a Career Development Award and a Principal Investigator on grants funded by the National Institute of Drug Abuse. His research interests include development of human laboratory and clinical trial models for testing medications to treat substance use disorders, including trials to improve effectiveness of antagonist-based treatment of opioid use disorder. Dr. Bisaga publishes and lectures in the area of addiction research and he is a member of the editorial board of the journal Addiction.